Ocular coloboma

Gene: VSX2

Green List (high evidence)

VSX2 (visual system homeobox 2)
EnsemblGeneIds (GRCh38): ENSG00000119614
EnsemblGeneIds (GRCh37): ENSG00000119614
OMIM: 142993, Gene2Phenotype
VSX2 is in 10 panels

1 review

Alice Gardham (Genomics England)

Green List (high evidence)

Recognised on G2P as causing coloboma
Created: 16 Nov 2016, 1:35 p.m.

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Microphthalmia with coloboma 3, 610092

Publications

Details

Mode of Inheritance
BIALLELIC, autosomal or pseudoautosomal
Sources
  • Expert Review Green
  • Emory Genetics Laboratory
  • Illumina TruGenome Clinical Sequencing Services
  • Radboud University Medical Center, Nijmegen
Phenotypes
  • Microphthalmia with coloboma 3, 610092
OMIM
142993
Clinvar variants
Variants in VSX2
Penetrance
Complete
Publications
Panels with this gene

History Filter Activity

6 Feb 2017, Gel status: 4

panel promoted to version 1

Alice Gardham (Genomics England)

Promoted to version 1 on 6th February 2016 by Alice Gardham

21 Dec 2016, Gel status: 4

Set Phenotypes

Alice Gardham (Genomics England)

Phenotypes for VSX2 were set to Microphthalmia with coloboma 3, 610092

19 Dec 2016, Gel status: 4

Set publications

Alice Gardham (Genomics England)

Publications for VSX2 were set to 10932181, 24859618

19 Dec 2016, Gel status: 4

Set Mode of Inheritance

Alice Gardham (Genomics England)

Mode of inheritance for VSX2 was changed to BIALLELIC, autosomal or pseudoautosomal

16 Nov 2016, Gel status: 4

Gene classified by Genomics England curator

Alice Gardham (Genomics England)

This gene has been classified as Green List (High Evidence).

16 Nov 2016, Gel status: 3

Upload gene information

Alice Gardham (Genomics England)

VSX2 was added to Ocular colobomapanel. Sources: Illumina TruGenome Clinical Sequencing Services,Emory Genetics Laboratory,Radboud University Medical Center, Nijmegen

11 May 2015, Gel status: 1

Added New Source

Eik Haraldsdottir (Genomics England)

VSX2 was added to Ocular colobomapanel. Sources: Radboud University Medical Center, Nijmegen